This week we come together to celebrate the bravery, compassion, and determination of nurses. There are currently more than four million nurses practicing in the United States, and they are some of the most trusted professionals across any industry. Amid today’s opioid epidemic, which has claimed the lives of over 70,000 Americans, the American Nurses Association (ANA) recognizes the critical … Read More
Data science has emerged as an ally for hospital directors of pharmacy in the continuous effort to close the “diversion gap”—the space where tracking and controls are incomplete and diverters conceal their activity. Simple math such as standard deviation and averages have proven inadequate in identifying diverters who have become adept at covering their tracks. However, new machine learning algorithms … Read More
Yesterday, Kit Check announced the launch of a new feature for Bluesight for Controlled Substances, the Individual Risk Identification Score (IRIS). Venture Beat covered the announcement as IRIS uses artificial intelligence to predict which employees pose the highest risk for controlled substance theft. Kit Check CEO Kevin MacDonald commented in the article, “The technology calculates how unusual one’s behavior is … Read More
In the day-to-day battle against drug diversion, most solutions look at the data to find statistical outliers. Often the focus is on clinicians who may be logging more transactions than their peers, or on medications that are administered in unusual amounts or that go missing. We can call this the “Who” and the “What.” But we really have to look … Read More
Children’s Hospital of the King’s Daughters (CHKD) in Virginia is not unlike most hospitals in the United States. Preventing medication diversion was a clear priority, but identifying incidents was like finding a needle in a haystack. Moving from Manual to ADCs Created a Data Gap CHKD had a manual, paper-based controlled substance auditing process and a full-time pharmacist dedicated … Read More
Health Connect Partners Fall 17 (#hcpchicago) just wrapped up in Chicago and, wow, was it a great show. While interacting with all of the pharmacy thought leaders in attendance, the topic that kept coming up was the issue of controlled substance compliance. The stage could not have been more ideally set for the unveiling of our latest product, Bluesight for Controlled Substances.
HCP Fall 17 is next week in Chicago. While I always enjoy HCP, this year’s event will be particularly meaningful for me. Not only is the event taking place in my hometown, Kit Check is launching an exciting new product to help hospitals get a better handle on controlled substance monitoring from dock to doc.
As the national conversation around opioid abuse continues to grow, hospitals grappling with citations, fines and the bad publicity that accompany these events are looking for solutions that can have both an immediate reduction in liability and set them up for long-term compliance and risk abatement.
As the opioid epidemic continues to make headlines, hospitals are facing increasing pressure to detect and prevent controlled substance diversion. In response, the American Society of Health-System Pharmacists (ASHP) released guidelines on developing a comprehensive diversion prevention program which builds upon similar publications by the CDC, DEA and The Joint Commission. Given the risks, hospitals should heed these guidelines to ensure they have the safeguards in place to avoid similar incidents that have plagued the headlines.
In case you missed it, Kit Check recently released the results of our annual Anesthesia Medication Tracking Survey. This survey focuses on the pain points in anesthesia medication tracking, wasting, and discrepancy reconciliation. For those of you looking for a more visual summary of our findings, we made this easy to read infographic that outlines a few key takeaways.